I am from Colombia and came to Germany for my studies in pharmaceutical bioprocess engineering (Pharmazeutische Bioprozesstechnik) that started in October 2019. One of my goals is to collaborate on the investigation and cure of diseases, which is why August 2019 I joined our research group. Appart from my studies I like to read and see new places in this beautiful county.
School of Life Sciences Weihenstephan - Technical University of Munich
I completed my undergraduate degree in Molecular Biology and Genetics at McMaster University in Canada in 2022. Following this, I pursued a Master’s degree in Biochemistry and Biomedical Sciences, also at McMaster University, where I focused on elucidating the mechanisms of action of novel therapeutics targeting acute myeloid leukemia (AML).
In 2024, I joined the AG Saur lab as a Ph.D. researcher. My current work focuses on understanding the environmental factors which drive heterogeneity within pancreatic ductal adenocarcinoma (PDAC), with the aim of identifying and characterize the contributors to clonal evolution in PDAC tumors.
PDAC subtypes Tumor microenvironment and combinatorial therapy strategy
I finished my undergrad in Biotechnology at Atma Jaya University, Indonesia (2017). Then I continued with my master’s degree in cell biology at TU Kaiserslautern, Germany (2021), where I analyzed the phenotypic consequences of polyploidy, which is a hallmark of cancer. In 2022 I joined the AG Saur group as Ph.D. researcher. I mainly work on defining the subtype-specific inflammatory drivers in PDAC and investigate its combinatorial therapy using a mouse model.